Conjunctivitis secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Secondary prevention strategies following conjunctivitis include [[ocular]] [[prophylaxis]] with 0.5% [[erythromycin]] [[ointment]] or 1% [[tetracycline hydrochloride]] (all [[newborns]]), discontinued [[contact lens]] wear (infective conjunctivitis), identify the [[allergen]] and avoid the [[antigen]] ([[allergic conjunctivitis]]).  
Secondary prevention strategies following conjunctivitis include discontinued [[contact lens]] wear (infective conjunctivitis), identify the [[allergen]] and avoid the offending [[antigen]] ([[allergic conjunctivitis]]), and [[ocular]] [[prophylaxis]] with 0.5% [[erythromycin]] [[ointment]] or 1% [[tetracycline hydrochloride]] ([[ophthalmia neonatorum]]).  
Secondary prevention strategies following [[keratoconjunctivitis sicca|keratoconjunctivitis sicca (dry eye syndrome)]] include avoid very dry environments, dusty and smoky areas and prolonged visual tasks.
Secondary prevention strategies following [[keratoconjunctivitis sicca|keratoconjunctivitis sicca (dry eye syndrome)]] include avoid very dry environments, dusty and smoky areas and prolonged visual tasks.
There is no established method for secondary prevention of superior limbic Keratoconjunctivitis. However, educating patients about disease process can improve compliance of patients with treatment, and help them to cope with the often prolonged symptoms.<ref name="pmid17696792">{{cite journal| author=Rose P| title=Management strategies for acute infective conjunctivitis in primary care: a systematic review. | journal=Expert Opin Pharmacother | year= 2007 | volume= 8 | issue= 12 | pages= 1903-21 | pmid=17696792 | doi=10.1517/14656566.8.12.1903 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17696792  }} </ref><ref name="pmid24235191">{{cite journal| author=Matejcek A, Goldman RD| title=Treatment and prevention of ophthalmia neonatorum. | journal=Can Fam Physician | year= 2013 | volume= 59 | issue= 11 | pages= 1187-90 | pmid=24235191 | doi= | pmc=3828094 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24235191  }} </ref><ref name="pmid23497516">{{cite journal| author=La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S et al.| title=Allergic conjunctivitis: a comprehensive review of the literature. | journal=Ital J Pediatr | year= 2013 | volume= 39 | issue=  | pages= 18 | pmid=23497516 | doi=10.1186/1824-7288-39-18 | pmc=3640929 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23497516  }} </ref><ref name="pmid25686388">{{cite journal| author=Messmer EM| title=The pathophysiology, diagnosis, and treatment of dry eye disease. | journal=Dtsch Arztebl Int | year= 2015 | volume= 112 | issue= 5 | pages= 71-81; quiz 82 | pmid=25686388 | doi=10.3238/arztebl.2015.0071 | pmc=4335585 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25686388  }} </ref><ref name="pmid2695351">{{cite journal| author=Nelson JD| title=Superior limbic keratoconjunctivitis (SLK). | journal=Eye (Lond) | year= 1989 | volume= 3 ( Pt 2) | issue=  | pages= 180-9 | pmid=2695351 | doi=10.1038/eye.1989.26 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2695351  }} </ref>
There is no established method for secondary prevention of superior limbic Keratoconjunctivitis. However, educating patients about disease process can improve compliance of patients with treatment, and help them to cope with the often prolonged symptoms.<ref name="pmid17696792">{{cite journal| author=Rose P| title=Management strategies for acute infective conjunctivitis in primary care: a systematic review. | journal=Expert Opin Pharmacother | year= 2007 | volume= 8 | issue= 12 | pages= 1903-21 | pmid=17696792 | doi=10.1517/14656566.8.12.1903 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17696792  }} </ref><ref name="pmid24235191">{{cite journal| author=Matejcek A, Goldman RD| title=Treatment and prevention of ophthalmia neonatorum. | journal=Can Fam Physician | year= 2013 | volume= 59 | issue= 11 | pages= 1187-90 | pmid=24235191 | doi= | pmc=3828094 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24235191  }} </ref><ref name="pmid23497516">{{cite journal| author=La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S et al.| title=Allergic conjunctivitis: a comprehensive review of the literature. | journal=Ital J Pediatr | year= 2013 | volume= 39 | issue=  | pages= 18 | pmid=23497516 | doi=10.1186/1824-7288-39-18 | pmc=3640929 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23497516  }} </ref><ref name="pmid25686388">{{cite journal| author=Messmer EM| title=The pathophysiology, diagnosis, and treatment of dry eye disease. | journal=Dtsch Arztebl Int | year= 2015 | volume= 112 | issue= 5 | pages= 71-81; quiz 82 | pmid=25686388 | doi=10.3238/arztebl.2015.0071 | pmc=4335585 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25686388  }} </ref><ref name="pmid2695351">{{cite journal| author=Nelson JD| title=Superior limbic keratoconjunctivitis (SLK). | journal=Eye (Lond) | year= 1989 | volume= 3 ( Pt 2) | issue=  | pages= 180-9 | pmid=2695351 | doi=10.1038/eye.1989.26 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2695351  }} </ref>
Line 13: Line 13:
* Discontinued [[contact lens]] wear ('''infective Conjunctivitis''')
* Discontinued [[contact lens]] wear ('''infective Conjunctivitis''')
===Neonatal Conjunctivitis===
===Neonatal Conjunctivitis===
Effective measures for the secondary prevention of neonatal conjunctivitis include:<ref name="pmid24235191">{{cite journal| author=Matejcek A, Goldman RD| title=Treatment and prevention of ophthalmia neonatorum. | journal=Can Fam Physician | year= 2013 | volume= 59 | issue= 11 | pages= 1187-90 | pmid=24235191 | doi= | pmc=3828094 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24235191  }} </ref>
Effective measures for the secondary prevention of neonatal conjunctivitis ([[ophthalmia neonatorum]]) include:<ref name="pmid24235191">{{cite journal| author=Matejcek A, Goldman RD| title=Treatment and prevention of ophthalmia neonatorum. | journal=Can Fam Physician | year= 2013 | volume= 59 | issue= 11 | pages= 1187-90 | pmid=24235191 | doi= | pmc=3828094 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24235191  }} </ref>
* [[Ocular]] [[prophylaxis]] with 0.5% [[erythromycin]] [[ointment]] or 1% [[tetracycline hydrochloride]] be given to all newborns.
* [[Ocular]] [[prophylaxis]] with 0.5% [[erythromycin]] [[ointment]] or 1% [[tetracycline hydrochloride]] be given to all newborns.
===Allergic conjunctivitis===
===Allergic conjunctivitis===
Line 21: Line 21:
===Keratoconjunctivitis Sicca===  
===Keratoconjunctivitis Sicca===  
Effective measures for the secondary prevention of [[keratoconjunctivitis sicca|keratoconjunctivitis sicca (dry eye syndrome)]] include:<ref name="pmid25686388">{{cite journal| author=Messmer EM| title=The pathophysiology, diagnosis, and treatment of dry eye disease. | journal=Dtsch Arztebl Int | year= 2015 | volume= 112 | issue= 5 | pages= 71-81; quiz 82 | pmid=25686388 | doi=10.3238/arztebl.2015.0071 | pmc=4335585 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25686388  }} </ref>
Effective measures for the secondary prevention of [[keratoconjunctivitis sicca|keratoconjunctivitis sicca (dry eye syndrome)]] include:<ref name="pmid25686388">{{cite journal| author=Messmer EM| title=The pathophysiology, diagnosis, and treatment of dry eye disease. | journal=Dtsch Arztebl Int | year= 2015 | volume= 112 | issue= 5 | pages= 71-81; quiz 82 | pmid=25686388 | doi=10.3238/arztebl.2015.0071 | pmc=4335585 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25686388  }} </ref>
*Avoid very dry environments (Furnaces and air conditioning can dry the air)  
*Avoid very [[dry]] environments (Furnaces and air conditioning can dry the air)  
*Use a humidifier (puts moisture back into the air to prevent [[dry eyes]])
*Use a humidifier (puts moisture back into the air to prevent [[dry eyes]])
*Avoid dusty and smoky areas  
*Avoid dusty and smoky areas  
*Avoid prolonged visual tasks (staring at a computer screen, driving, watching television, and reading)
*Avoid prolonged [[visual]] tasks (staring at a computer screen, driving, watching television, and reading)
*Promptly use [[artificial tears]]
*Promptly use [[artificial tears]]
===Superior Limbic Keratoconjunctivitis===
===Superior Limbic Keratoconjunctivitis===
There is no established method for secondary prevention of superior limbic keratoconjunctivitis. However, educating patients about disease process can improve compliance of patients with treatment, and help them to cope with the often prolonged symptoms.<ref name="pmid2695351">{{cite journal| author=Nelson JD| title=Superior limbic keratoconjunctivitis (SLK). | journal=Eye (Lond) | year= 1989 | volume= 3 ( Pt 2) | issue=  | pages= 180-9 | pmid=2695351 | doi=10.1038/eye.1989.26 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2695351  }} </ref>
There is no established method for secondary prevention of superior limbic keratoconjunctivitis. However, educating patients about [[disease process]] can improve [[compliance]] of patients with treatment, and help them to cope with the often prolonged symptoms.<ref name="pmid2695351">{{cite journal| author=Nelson JD| title=Superior limbic keratoconjunctivitis (SLK). | journal=Eye (Lond) | year= 1989 | volume= 3 ( Pt 2) | issue=  | pages= 180-9 | pmid=2695351 | doi=10.1038/eye.1989.26 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2695351  }} </ref>
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 12:27, 8 July 2016

Conjunctivitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Conjunctivitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Conjunctivitis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Conjunctivitis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Conjunctivitis secondary prevention

CDC on Conjunctivitis secondary prevention

Conjunctivitis secondary prevention in the news

Blogs on Conjunctivitis secondary prevention

Directions to Hospitals Treating Conjunctivitis

Risk calculators and risk factors for Conjunctivitis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Secondary prevention strategies following conjunctivitis include discontinued contact lens wear (infective conjunctivitis), identify the allergen and avoid the offending antigen (allergic conjunctivitis), and ocular prophylaxis with 0.5% erythromycin ointment or 1% tetracycline hydrochloride (ophthalmia neonatorum). Secondary prevention strategies following keratoconjunctivitis sicca (dry eye syndrome) include avoid very dry environments, dusty and smoky areas and prolonged visual tasks. There is no established method for secondary prevention of superior limbic Keratoconjunctivitis. However, educating patients about disease process can improve compliance of patients with treatment, and help them to cope with the often prolonged symptoms.[1][2][3][4][5]

Secondary Prevention

Infective Conjunctivitis

Effective measure for the secondary prevention of infective conjunctivitis include:[1]

Neonatal Conjunctivitis

Effective measures for the secondary prevention of neonatal conjunctivitis (ophthalmia neonatorum) include:[2]

Allergic conjunctivitis

Effective measures for the secondary prevention of allergic conjunctivitis include:[3]

Keratoconjunctivitis Sicca

Effective measures for the secondary prevention of keratoconjunctivitis sicca (dry eye syndrome) include:[4]

  • Avoid very dry environments (Furnaces and air conditioning can dry the air)
  • Use a humidifier (puts moisture back into the air to prevent dry eyes)
  • Avoid dusty and smoky areas
  • Avoid prolonged visual tasks (staring at a computer screen, driving, watching television, and reading)
  • Promptly use artificial tears

Superior Limbic Keratoconjunctivitis

There is no established method for secondary prevention of superior limbic keratoconjunctivitis. However, educating patients about disease process can improve compliance of patients with treatment, and help them to cope with the often prolonged symptoms.[5]

References

  1. 1.0 1.1 Rose P (2007). "Management strategies for acute infective conjunctivitis in primary care: a systematic review". Expert Opin Pharmacother. 8 (12): 1903–21. doi:10.1517/14656566.8.12.1903. PMID 17696792.
  2. 2.0 2.1 Matejcek A, Goldman RD (2013). "Treatment and prevention of ophthalmia neonatorum". Can Fam Physician. 59 (11): 1187–90. PMC 3828094. PMID 24235191.
  3. 3.0 3.1 La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S; et al. (2013). "Allergic conjunctivitis: a comprehensive review of the literature". Ital J Pediatr. 39: 18. doi:10.1186/1824-7288-39-18. PMC 3640929. PMID 23497516.
  4. 4.0 4.1 Messmer EM (2015). "The pathophysiology, diagnosis, and treatment of dry eye disease". Dtsch Arztebl Int. 112 (5): 71–81, quiz 82. doi:10.3238/arztebl.2015.0071. PMC 4335585. PMID 25686388.
  5. 5.0 5.1 Nelson JD (1989). "Superior limbic keratoconjunctivitis (SLK)". Eye (Lond). 3 ( Pt 2): 180–9. doi:10.1038/eye.1989.26. PMID 2695351.

Template:WS Template:WH